Eco Depot New CEO to Establish Product Deployment and Distribution Platform
Eco Depot New CEO to Establish Product Deployment and Distribution Platform Toronto, Ontario–(Newsfile Corp. – January 21, 2021) – Eco
Read more
BIOTCHNO
Cecors, Inc. Shareholder Update
Cecors, Inc. Shareholder Update Las Vegas, Nevada–(Newsfile Corp. – January 14, 2021) – CECORS, INC. (OTC PINK: CEOS) (“CeCors” or
Read more
AVECTAS Appoints Daniel Castro as Chief Business Officer
– Newly created role of Chief Business Officer to drive commercialization strategy including partnering SOLUPORE®, Avectas’ non-viral cell engineering technology
Read more
Mediwelcome: Key Player in the Gold Track, is Forming a Head Leading Advantage
Mediwelcome: Key Player in the Gold Track, is Forming a Head Leading Advantage HONG KONG, Jan 6, 2021 – (ACN
Read more
The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition
Canada NewsWire PISA, Italy,Dec. 23, 2020/CNW/ —PharmaNutra S.p.A.(the “Company“), specialised in iron-based nutritional supplements and in medical devices for muscles
Read more
Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;} SCHAFFHAUSEN,Switzerland,Dec. 18, 2020/CNW/ — Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA)
Read more
Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)
/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:”Arial”; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:”Arial”; color:black; }
Read more
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody
Read more
Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts
–Retrospective analyses of the Phase 3 SIMPLIFY studies demonstrate safety and activity profile are not impacted by baseline platelet count–
Read more
enGene Receives Fast Track Designation for EG-70 for the Treatment of Non-Muscle Invasive Bladder Cancer
BOSTONand MONTRÉAL,Dec. 3, 2020/CNW Telbec/ – enGene Inc., a biotechnology company developing non-viral gene therapies for local administration into mucosal tissues enabled
Read more